Fludarabine is a chemotherapeutic agent used in the treatment of hematological malignancies. It is commonly marketed under the brand name Fludara.
For the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen
Affiliated Hospital of Nantong University, Nantong, Jiangsu, China
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
University Hospitals Cleveland Medical Center Seidman Cancer Center, Cleveland, Ohio, United States
Seoul National University Hosptial, Seoul, Korea, Republic of
Asan Medical Center, Seoul, Korea, Republic of
Samsung Medical Center, Seoul, Korea, Republic of
The First Affiliated Hospital of Soochow University, Suzhou, China, Jiangsu, China
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
University of California San Francisco, San Francisco, California, United States
AdventHealth Orlando - Adventist Health System/Sunbelt, Inc., Orlando, Florida, United States
Stanford University, Stanford, California, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.